Pacira | PCRX - Current Assets



Pacira reported $745.61M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Astellas Pharma JPY 1.29T 91.98B Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Ironwood Pharmaceuticals USD 182.42M 3.81M Dec/2024
J&J USD 71.55B 15.66B Mar/2025
Ligand Pharmaceuticals USD 352.94M 43.63M Jun/2025
Novo Nordisk 162.71B 11.69B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025
Zoetis USD 5.92B 46M Jun/2025